IDENTIFYING NON-ALCOHOLIC FATTY LIVER DISEASE AMONG ASYMPTOMATIC OVERWEIGHT AND OBESE INDIVIDUALS BY CLINICAL AND BIOCHEMICAL CHARACTERISTICS

REFERENCES

• Farrell GC, Larter CZ. Nonalcohlic fatty liver disease: from ste-atosis to cirrhosis. Hepatology 2006; 43 (2 Suppl 1):S99–S112.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ. AGA Technical review on nonalcoholic fatty liver dis-ease. Gastroenterology 2002;123:1705–1725.
   PubMedGoogle Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–1231.
   PubMed Web of Science ®Google Scholar
• Bellentani S, Saccoccio G, Masatti F, Croce LS, Brandi G, Sasso F, Cristanini G, and Tribelli C. Prevalence of and risk factors for liver steatosis in Northern Italy. Ann Intern Med 2000;132:112–117.
   PubMed Web of Science ®Google Scholar
• Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver dis-ease. Gastroenterology 2002; 122:1649–1657.
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver dis-ease: predictors of nonalcoholic steatohepatitis and liver fibro-sis in the severely obese. Gastroenterology 200; 121:91–100.
   Google Scholar
• Adams LA, Lymp JF, Sauver J, Sanderson SO, Lindor KD, Feld-stein A, Angulo P. The natural history of nonalcoholic fatty liver: a population based cohort study. Gastroenterology 2005;129:113–121.
   PubMed Web of Science ®Google Scholar
• Samuel VT, Liu Z-X, Qu X, Elder BD, Bilz S, Befroy D et al. Mech-anism of hepatic insulin resistance in non-alcoholic fatty liver disease.] Biol Chem 2004;279:32345–53.
   PubMed Web of Science ®Google Scholar
• Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nu-trition Examination Survey. Circulation. 2004; 109:42–6.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, Falezza G. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol (Oxf) 2006; 64: 679–683.
   PubMed Web of Science ®Google Scholar
• Kim Si, Kim HY, Seo JA, Lee KW, Oh JH, Kim NH, Choi KM, Baik SH, Choi DS. Relationship between serum adiponectin concen-tration, pulse wave velocity and nonalcoholic fatty liver dis-ease. Eur J Endocrinol 2005; 152: 225–231.
   PubMed Web of Science ®Google Scholar
• Larter CZ, Farrell GC. Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat?] Hepatol 2006; 44: 253–261.
   PubMed Web of Science ®Google Scholar
• Mendez-Sanchez N, Chavez-Tapia NC, Villa AR, Sanchez-Lara K, Zamora-Valdes D, Ramos MH, Uribe M. Adiponectin as a pro-tective factor in hepatic steatosis. World] Gastroenterol 2005; 11: 1737–1741.
   PubMed Web of Science ®Google Scholar
• Schaffier A, Scholmerich J, Buchler C. Mechanism of disease:adipocytokines and visceral adipose tissue - emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroen-terol Hepatol 2005; 2:273–280.
   Web of Science ®Google Scholar
• Matsubara M. Plasma Adiponectin decrease in women with nonalcoholic fatty liver. EndocrJ 2004; 51: 587–593.
   Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon Mi. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.] Clin Endocrinol Metab 2000; 85: 2402–2410.
   PubMed Web of Science ®Google Scholar
• Executive Summary of the Third Report of the National Cho-lesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486–2497.
   PubMed Web of Science ®Google Scholar
• Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR. Comparison of different definitions of the metabolic syn-drome. Eur J Clin Invest. 2007; 37:109–16.
   PubMed Web of Science ®Google Scholar
• Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultra-sonographical diagnosis of fatty liversignificance of the liver kidney contrast. Tohoku J Exp Med 1983;139:43–50.
   PubMed Web of Science ®Google Scholar
• Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ 1986; 292: 13–15.
   PubMed Web of Science ®Google Scholar
• Swets JA. Measuring the accuracy of diagnostic systems. Sci-ence 1988; 240: 1285–93.
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148:839–43.
   PubMed Web of Science ®Google Scholar
• The Evidence-Based Medicine Working Group. Users' guides to the medical literature. A Manual for Evidence-Based Clini-cal Practice. Edited by Gordon Guyatt and Drummond Rennie. American Medical Association Press, 2002, Chicago., Illinois.
   Google Scholar
• Nasrallah SM, Wills CE Jr, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci 1981; 26: 325–327.
   PubMed Web of Science ®Google Scholar
• Scheen AJ, Luyckx FH. Obesity and liver disease. Best Pract Res Clin Endocrinol Metab 2002;16: 703–716.
   PubMed Web of Science ®Google Scholar
• Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepa-tology 1990; 12: 1106–1110.
   PubMed Web of Science ®Google Scholar
• Andersen T, Gluud C. Liver morphology in morbid obesity: a literature survey. Int] Obes 1984; 8:97–106.
   PubMed Web of Science ®Google Scholar
• Hague M, Sanyal AJ. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gas-troenterol 2002; 16: 709–731.
   PubMed Web of Science ®Google Scholar
• Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjoro K, Aukrust P. Systemic inflammation in nonalcoholic fatty liver disease is character-ized by elevated levels of CCL2. J Hepatol. 2006; 44: 1167–1174.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalco-holic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16:421–427.
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Faga E, Pacini G, De Michieli F, Rabbione L, Premoli A, Cassader M, Pa-gano G. Adipokines in NASH: postprandial metabolism as a link between adiponeectin and liver disease. Hepatology 2005; 42,1175–1183.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Scala L, Poll F, Zenari L, Falezza G. De-creased plasma adiponectin concentrations are closely associ-ated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol (Oxf) 2004; 61: 700–703.
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de lasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.] Clin Endocrinol Metab 2005; 90: 3498–3504.
   PubMed Web of Science ®Google Scholar
• Lonardo A, Carani C, Carulli N, Loria P. Endocrine NAFLD' a hor-monocentric perspective of nonalcoholic fatty liver disease pathogenesis.] Hepatol. 2006; 44(6): 1196–207.
   Web of Science ®Google Scholar
• Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis:an expanded clinical entity. Gas-troenterology 1994; 107:1103–1109.
   PubMed Web of Science ®Google Scholar
• Tell MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatol-ogy 1995; 22: 1714–1719.
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Harrison SA, Torgerson S, Perez TA, Nochajski T, Russell M. Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Am] Gastroenterol 2004; 99: 76–81.
   PubMed Web of Science ®Google Scholar
• Haentjens P, Annemans L. Health economics and the orthopae-dic surgeon. ] Bone Joint Surg Br. 2003; 85-B: 1093–1099.
   Web of Science ®Google Scholar
• Montori VM, Wyer P, Newman TB, Keitz S, Guyatt G, for the Evidence-based Medicine Teaching Tips Working Group. Tips for teachers of evidence-based medicine: 5.The effect of spectrum of disease on the performance of diagnostic tests. CMAJ 2005; 173: 385–390.
   PubMed Web of Science ®Google Scholar
• Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM. Empirical evidence of design-related bias in studies of diagnostic tests. /AMA 1999; 282: 1061–6.
   PubMed Web of Science ®Google Scholar
• Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy stud-ies. CMAJ. 2006; 174: 469–76.
   PubMed Web of Science ®Google Scholar